GO:1903903 regulation of establishment of T cell polarity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1903903 describes any process that modulates the frequency, rate or extent of establishment of T cell polarity, a prerequisite for directed T cell migration, immune synapse formation and effector function.
• T cell polarity establishment is controlled by chemokine gradients, integrin signaling and actin cytoskeleton reorganization, and its dysregulation is linked to autoimmunity and cancer.
• Key regulators include ANKRD55, which is a critical mediator of T cell inflammation in multiple sclerosis, and ILT4, which modulates T cell dysfunction in lung cancer.
• The term is a biological process and is distinct from the establishment of T cell polarity itself; it encompasses positive and negative regulatory inputs.
• Experimental dissection of GO:1903903 benefits from CRISPR knockout, point-mutation, knock-in and overexpression models to test causality of candidate regulators.
• Altered regulation of T cell polarity contributes to immunosuppressive microenvironments in tumors and to chronic inflammatory diseases, making it a therapeutic target.
Description
Regulation of establishment of T cell polarity (GO:1903903) is a biological process that encompasses any molecular event that modulates the frequency, rate or extent of the establishment of T cell polarity. T cell polarity is the asymmetric organization of cellular components that enables a T lymphocyte to orient its secretory machinery, migrate directionally and form a functional immune synapse. Because this process is fundamental to adaptive immunity, its regulatory mechanisms are of intense research interest. Dysregulated T cell polarity has been implicated in autoimmune diseases such as multiple sclerosis and in cancer immune evasion. For example, ANKRD55 has been identified as a key regulator of T cell inflammation in multiple sclerosis, highlighting the importance of polarity control in disease pathogenesis. In non-small cell lung cancer with EGFR activation, inhibition of ILT4 prevents dysfunctional T cell-mediated immunosuppression, suggesting that polarity-related signaling can be therapeutically targeted. This article synthesizes current knowledge on GO:1903903, its core components, regulatory inputs, disease relevance and experimental approaches, based strictly on published literature.
regulation of establishment of T cell polarity At A Glance
| GO ID | GO:1903903 |
|---|---|
| GO term | regulation of establishment of T cell polarity |
| Ontology | biological_process |
| Synonym | regulation of establishment of T-cell polarity; regulation of establishment of T lymphocyte polarity; regulation of establishment of T-lymphocyte polarity; regulation of T cell polarization; regulation of T-cell polarization; regulation of T lymphocyte polarization |
| Major function | Modulates the frequency, rate or extent of T cell polarity establishment, influencing migration, immune synapse formation and effector responses. |
| Related processes | T cell activation, chemotaxis, immune synapse assembly, cytoskeletal reorganization. |
| Disease relevance | Multiple sclerosis, cancer immunosuppression, chronic inflammation. |
| Key regulators | ANKRD55, ILT4, and other signaling molecules. |
What Is GO:1903903?
GO:1903903 is defined as any process that modulates the frequency, rate or extent of establishment of T cell polarity. In other words, it includes all signaling and molecular events that positively or negatively control the asymmetric reorganization of a T cell, without being the establishment process itself. This regulation ensures that T cells polarize appropriately in response to chemokines, antigens and environmental cues.
Why Is regulation of establishment of T cell polarity Important in Cell Biology?
Understanding the regulation of T cell polarity is crucial because it governs fundamental T cell behaviors such as directional migration, antigen recognition and targeted secretion of cytokines and cytotoxic molecules. Perturbations in this regulatory process can lead to defective immune responses, autoimmunity or tumor immune evasion. Therefore, identifying the molecular players that control T cell polarity establishment offers opportunities for therapeutic intervention in inflammatory diseases and cancer.
• Controls T cell migration and localization within tissues.
• Essential for immune synapse formation and T cell activation.
• Dysregulation contributes to multiple sclerosis pathogenesis.
• Modulates anti-tumor immunity and response to immunotherapy.
• Influences T cell dysfunction in the tumor microenvironment.
• Potential target for enhancing checkpoint inhibitor efficacy.
• Required for effective adaptive immune responses.
• Links environmental cues to cytoskeletal remodeling.
• Implicated in chronic inflammatory conditions.
• Provides a mechanistic basis for precision medicine approaches.
What Happens During regulation of establishment of T cell polarity?
Initiation by chemokine and antigen receptor signaling
In simple terms: Signals from outside the cell start the process of making a T cell asymmetric.
Regulation of T cell polarity begins with extracellular cues such as chemokines and antigen recognition, which activate intracellular signaling pathways. These signals converge on small GTPases and lipid kinases to initiate polarization.
Cytoskeletal reorganization and asymmetric protein distribution
In simple terms: The cell's skeleton rearranges to create a front and back.
Downstream of initiation, actin and microtubule networks are reorganized to establish a leading edge and a uropod, with specific proteins targeted to each pole. This asymmetry is essential for directed migration and immune synapse formation.
Modulation by immune checkpoints and cytokines
In simple terms: Other immune molecules can turn the polarity process up or down.
Regulatory inputs include inhibitory receptors such as ILT4, which can suppress T cell function and affect polarity-related signaling in the tumor microenvironment. Cytokines such as IL-17 produced by γδ T cells can also influence T cell polarization states in cancer.
Integration with metabolic and transcriptional programs
In simple terms: The cell's metabolism and gene expression can adjust polarity.
Metabolic factors such as lactate accumulation driven by NDRG1 can promote an immunosuppressive microenvironment that impacts T cell polarity and function. Additionally, commensal microbe-derived butyrate induces regulatory T cell differentiation, which may indirectly affect polarity regulation.
Key Genes Involved in GO:1903903 regulation of establishment of T cell polarity
The following genes and proteins have been experimentally linked to the regulation of T cell polarity or related T cell functions, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ANKRD55 | Key regulator of T cell inflammation | Associated with multiple sclerosis; potential target for modulating T cell polarity. |
| ILT4 | Inhibitory receptor modulating T cell dysfunction | Inhibition prevents immunosuppression and enhances anti-PD-L1 therapy in NSCLC. |
| NDRG1 | Drives lactate accumulation and immunosuppressive microenvironment | Promotes lung adenocarcinoma progression; affects T cell function. |
| IL-17 | Pro-inflammatory cytokine produced by γδ T cells | Promotes breast cancer metastasis via neutrophil recruitment. |
| Butyrate | Microbial metabolite inducing Treg differentiation | Impacts colonic regulatory T cell development. |
| MerTK | Mediates efferocytosis and immune tolerance | Enhances M2 polarization and PD-L1 expression in osteosarcoma. |
| IL-10 | Regulates innate immunity and tissue-resident memory T cells | Optimizes protection in lung tissue. |
| cDC2 | Conventional dendritic cell subset | Homeostatic maturation drives tolerogenic state. |
| PD-L1 | Immune checkpoint ligand | Target of anti-PD-L1 therapy; modulated by ILT4 inhibition. |
| EGFR | Receptor tyrosine kinase | Activation linked to immunosuppression in NSCLC. |
| TAM | Tumor-associated macrophages | Mediate immunosuppression; affected by ILT4 inhibition. |
| γδ T cells | Unconventional T cell subset | Produce IL-17 and promote metastasis. |
| Neutrophils | Innate immune cells | Conspire with γδ T cells to promote metastasis. |
| Treg | Regulatory T cells | Induced by butyrate; suppress immune responses. |
| TRM | Tissue-resident memory T cells | Regulated by IL-10 to optimize protection. |
How Is regulation of establishment of T cell polarity Regulated?
The regulation of T cell polarity establishment is itself modulated by various signaling pathways. For instance, ILT4 inhibition can prevent T cell dysfunction and enhance anti-PD-L1 therapy efficacy, indicating that checkpoint molecules regulate polarity-related processes. Metabolic factors such as lactate, driven by NDRG1, can create an immunosuppressive microenvironment that impairs T cell function. Additionally, commensal microbe-derived butyrate promotes regulatory T cell differentiation, which may influence the balance of T cell polarity states. These examples illustrate that GO:1903903 is subject to regulation by immune checkpoints, metabolic cues and microbial metabolites.
regulation of establishment of T cell polarity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ANKRD55 | Multiple sclerosis | Knockout or point-mutation in T cell lines; EAE model |
| ILT4 | NSCLC with EGFR activation | Knockout in T cells; co-culture with tumor cells |
| NDRG1 | Lung adenocarcinoma | Overexpression or knockout in cancer cells; T cell co-culture |
| MerTK | Osteosarcoma | Knockout in macrophages; tumor progression models |
| IL-10 | Lung infection and tissue-resident memory | Knockout mice; infection models |
Multiple Sclerosis
ANKRD55 has been identified as a key regulator of T cell inflammation in multiple sclerosis, suggesting that dysregulation of T cell polarity contributes to autoimmune neuroinflammation. Targeting ANKRD55 or its downstream polarity pathways may offer therapeutic benefit.
Cancer Immunosuppression
In non-small cell lung cancer with EGFR activation, ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy. This indicates that regulation of T cell polarity is critical for effective anti-tumor immunity. Similarly, NDRG1-driven lactate accumulation promotes lung adenocarcinoma progression through an immunosuppressive microenvironment, further linking polarity regulation to cancer.
Breast Cancer Metastasis
IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis, highlighting how T cell polarization states can influence tumor progression.
Osteosarcoma
MerTK-mediated efferocytosis promotes immune tolerance and tumor progression in osteosarcoma through enhancing M2 polarization and PD-L1 expression, indicating a role for polarity regulation in the tumor microenvironment.
From regulation of establishment of T cell polarity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does ANKRD55 regulate T cell polarity in multiple sclerosis? | CRISPR knockout of ANKRD55 in primary human T cells or Jurkat cells |
| Does ILT4 inhibition enhance T cell polarity and anti-tumor activity? | ILT4 knockout in T cells followed by co-culture with NSCLC cells |
| Does NDRG1-driven lactate affect T cell polarity? | NDRG1 overexpression or knockout in lung adenocarcinoma cells; T cell functional assays |
| Does butyrate influence Treg polarity? | Knockout of butyrate receptors in T cells; differentiation assays |
| Does MerTK-mediated efferocytosis alter T cell polarity? | MerTK knockout in macrophages; co-culture with T cells |
| Does IL-10 regulate tissue-resident memory T cell polarity? | IL-10 knockout mice; lung infection models |
How to Study the regulation of establishment of T cell polarity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Live-cell imaging | Polarization dynamics and marker localization | Assessing regulators of T cell polarity |
| CRISPR knockout screening | Gene requirement for polarity | Identifying novel regulators |
| Phosphoproteomics | Signaling changes | Mapping regulatory phosphorylation |
| Proximity labeling | Protein interactions | Mapping immune synapse complexes |
| Migration assay | Directional motility | Functional readout of polarity |
| Immune synapse assay | Synapse formation and function | Evaluating T cell activation |
| Cytokine secretion | Effector function | Linking polarity to T cell responses |
| Flow cytometry | Surface marker expression | Quantifying T cell subsets |
Live-cell imaging of polarity markers
Live-cell imaging using fluorescently tagged polarity markers (e.g., GM1, CD44) allows real-time visualization of T cell polarization dynamics. This method can assess the effects of genetic perturbations on the regulation of polarity establishment.
CRISPR screening for regulators
Genome-wide CRISPR knockout or activation screens can identify novel regulators of T cell polarity. Hits can be validated by targeted knockout and imaging.
Phosphoproteomics and interactomics
Mass spectrometry-based phosphoproteomics can reveal signaling changes during polarity establishment, identifying regulatory phosphorylation events. Proximity labeling can map protein interactions at the immune synapse.
Functional immune assays
T cell migration, immune synapse formation and cytokine secretion assays provide functional readouts of polarity regulation. These assays are essential for linking molecular regulators to T cell function.
How CRISPR Can Be Used to Study GO:1903903 regulation of establishment of T cell polarity
Knockout
CRISPR knockout of candidate regulators such as ANKRD55 or ILT4 can determine their necessity for T cell polarity establishment. Knockout models are valuable for validating hits from screens.
Point Mutation
Point mutations can be introduced to dissect specific phosphorylation sites or domains required for polarity regulation. This approach helps distinguish between scaffolding and catalytic functions.
Knock-in
Knock-in of fluorescent tags or epitope tags allows visualization and biochemical isolation of polarity regulators in their endogenous context. Tagged knock-in models are useful for live-cell imaging and proteomics.
Overexpression
Overexpression of wild-type or mutant forms of polarity regulators can test sufficiency and gain-of-function effects. This is particularly useful for studying constitutively active or dominant-negative variants.
How EDITGENE Supports regulation of establishment of T cell polarity Research
Researchers studying regulation of establishment of T cell polarity-related genes often need to determine whether a candidate gene is causally involved in the process or is merely a bystander. This requires precise genetic manipulation, which can be achieved through CRISPR-based knockout, point mutation, knock-in and overexpression models. EDITGENE provides a comprehensive suite of services to support such investigations, from cell line generation to library screening and bioinformatics analysis.
Contact EDITGENE today to design your custom CRISPR model for regulation of establishment of T cell polarity research.
Frequently Asked Questions About regulation of establishment of T cell polarity
What is GO:1903903?
GO:1903903 is a Gene Ontology biological process term defined as any process that modulates the frequency, rate or extent of establishment of T cell polarity.
What genes are involved in regulation of establishment of T cell polarity?
Key genes include ANKRD55, which regulates T cell inflammation in multiple sclerosis, and ILT4, which modulates T cell dysfunction in cancer.
How is T cell polarity regulated?
T cell polarity is regulated by chemokine and antigen receptor signaling, cytoskeletal reorganization, immune checkpoints and metabolic cues.
Why is regulation of T cell polarity important in cancer?
Dysregulated T cell polarity can lead to immunosuppression and poor response to immunotherapy; targeting regulators like ILT4 can enhance anti-PD-L1 therapy.
What diseases are associated with abnormal T cell polarity regulation?
Multiple sclerosis, non-small cell lung cancer, breast cancer metastasis and osteosarcoma have been linked to altered T cell polarity regulation.
What experimental models are used to study GO:1903903?
CRISPR knockout, point mutation, knock-in and overexpression models in T cell lines and primary cells are commonly used.
How can CRISPR screening help identify regulators of T cell polarity?
Genome-wide CRISPR screens can uncover novel genes required for T cell polarity establishment, which can then be validated in functional assays.
What is the role of ANKRD55 in T cell polarity?
ANKRD55 is a key regulator of T cell inflammation in multiple sclerosis, likely influencing polarity-related signaling.
Can targeting ILT4 improve cancer immunotherapy?
Inhibition of ILT4 prevents T cell dysfunction and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
How does NDRG1 affect T cell polarity?
NDRG1-driven lactate accumulation promotes an immunosuppressive microenvironment that can impair T cell function, indirectly affecting polarity.
Conclusion
GO:1903903, regulation of establishment of T cell polarity, is a critical biological process that controls T cell migration, activation and effector functions. Its dysregulation is implicated in autoimmune diseases and cancer, making it a promising therapeutic target. Continued research using advanced CRISPR models and functional assays will further elucidate the molecular mechanisms and identify new intervention points.
References
- 1. Chen X et al.. 2021. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.. Theranostics 11(7):3392-3416 PMID: 33537094
- 2. Coffelt SB et al.. 2015. IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis.. Nature 522(7556):345-348 PMID: 25822788
- 3. Furusawa Y et al.. 2013. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells.. Nature 504(7480):446-50 PMID: 24226770
- 4. Wu C et al.. 2025. ANKRD55 is a key regulator of T cell inflammation in multiple sclerosis.. J Clin Invest 135(20) PMID: 41090353
- 5. Wu G et al.. 2025. NDRG1-Driven Lactate Accumulation Promotes Lung Adenocarcinoma Progression Through the Induction of an Immunosuppressive Microenvironment.. Adv Sci (Weinh) 12(33):e01238 PMID: 40539245
- 6. Yang AY et al.. 2026. Lung tissue-resident memory T cells optimize protection by IL-10 regulation of innate immunity.. J Exp Med 223(1) PMID: 41081716
- 7. Lin J et al.. 2022. MerTK-mediated efferocytosis promotes immune tolerance and tumor progression in osteosarcoma through enhancing M2 polarization and PD-L1 expression.. Oncoimmunology 11(1):2024941 PMID: 35036076
- 8. Lu M et al.. 2026. Homeostatic maturation programs drive human cDC2s into a tolerogenic state.. Immunity 59(5):1201-1220.e13 PMID: 41713421
